HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,666,000 | -14.7% | 150,000 | -9.5% | 0.25% | -28.9% |
| Q4 2018 | $4,298,000 | -20.1% | 165,682 | -2.5% | 0.35% | -0.3% |
| Q3 2018 | $5,381,000 | -27.5% | 170,000 | -11.0% | 0.35% | -36.2% |
| Q2 2018 | $7,425,000 | +40.8% | 191,108 | 0.0% | 0.55% | +39.7% |
| Q1 2018 | $5,275,000 | +45.7% | 191,108 | -4.4% | 0.39% | +3.7% |
| Q4 2017 | $3,620,000 | -60.7% | 200,000 | -64.9% | 0.38% | -76.7% |
| Q3 2017 | $9,206,000 | +16.6% | 570,000 | 0.0% | 1.62% | +24.2% |
| Q2 2017 | $7,894,000 | -56.1% | 570,000 | -52.5% | 1.31% | -50.0% |
| Q1 2017 | $18,000,000 | -29.6% | 1,200,000 | -38.5% | 2.61% | -24.1% |
| Q4 2016 | $25,562,000 | -16.2% | 1,951,263 | +10.2% | 3.45% | +2.4% |
| Q3 2016 | $30,519,000 | -4.5% | 1,771,263 | 0.0% | 3.36% | -25.8% |
| Q2 2016 | $31,971,000 | -3.8% | 1,771,263 | +1.2% | 4.53% | -9.4% |
| Q1 2016 | $33,233,000 | -26.2% | 1,750,000 | +3.8% | 5.01% | -7.0% |
| Q4 2015 | $45,009,000 | +9.4% | 1,685,719 | 0.0% | 5.38% | -18.0% |
| Q3 2015 | $41,132,000 | -8.3% | 1,685,719 | +17.1% | 6.57% | +10.1% |
| Q2 2015 | $44,870,000 | +142.8% | 1,440,000 | +13.4% | 5.97% | +108.9% |
| Q1 2015 | $18,479,000 | +162.4% | 1,270,000 | +81.4% | 2.86% | +163.0% |
| Q4 2014 | $7,042,000 | +20.8% | 700,000 | 0.0% | 1.09% | -9.4% |
| Q3 2014 | $5,831,000 | -32.4% | 700,000 | 0.0% | 1.20% | -47.5% |
| Q2 2014 | $8,624,000 | – | 700,000 | – | 2.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|